Angela Tanudra

High Prevalence of Spirochetosis in Cholera Patients, Bangladesh

Eric J. Nelson, A. Camilli, S. Calderwood, 2009, Emerging infectious diseases.

Rational design of a new antibiotic class for drug-resistant infections

S. McLeod, A. Ferguson, G. Drusano, 2021, Nature.

Pharmacokinetic/Pharmacodynamic Determination and Preclinical Pharmacokinetics of the β-Lactamase Inhibitor ETX1317 and Its Orally Available Prodrug ETX0282

Angela Tanudra, R. Tommasi, April Chen, 2020, ACS infectious diseases.

In vivo dose response and efficacy of the β-lactamase inhibitor, durlobactam, in combination with sulbactam against the Acinetobacter baumannii-calcoaceticus complex

S. McLeod, Angela Tanudra, J. O’Donnell, 2023, Antimicrobial agents and chemotherapy.

In vitro pharmacokinetics/pharmacodynamics of the β-lactamase inhibitor, durlobactam, in combination with sulbactam against Acinetobacter baumannii-calcoaceticus complex

S. McLeod, Angela Tanudra, Alita A. Miller, 2023, Antimicrobial agents and chemotherapy.